Literature DB >> 28410360

Estimation of Prevalence of Meibomian Gland Dysfunction in Japan.

Shiro Amano1, Kenji Inoue.   

Abstract

PURPOSE: To estimate the prevalence of meibomian gland dysfunction (MGD) in the Japanese population using new diagnostic criteria, including lid margin abnormalities and signs of occlusion of the meibomian gland orifices as essential signs.
METHODS: The participants were consecutive patients scheduled for cataract surgery at Inouye Eye Hospital. All participants were aged 50 years or older. The participants completed a symptoms questionnaire and underwent a comprehensive slit-lamp examination. MGD was diagnosed when both of the following 2 factors were positive: lid margin abnormalities and signs of occlusion of the meibomian gland orifices.
RESULTS: The study included 510 participants (205 men, 305 women) of mean age 71.1 ± 8.5 (range 50-93) years. The prevalence rates of symptomatic MGD and total (symptomatic + asymptomatic) MGD were 18.0% and 47.5%, respectively. The prevalence of total MGD increased significantly with increasing patient age (P < 0.0001). The ratio of men to women and the prevalence of systemic disease did not differ between participants who were positive or negative for MGD. For the total MGD group, slit-lamp findings (lid margin abnormality, shift of the mucocutaneous junction, telangiectasia, and plugging) were more frequent; tear film breakup time was shorter; and the meiboscore was higher than in participants without MGD.
CONCLUSIONS: The prevalence of MGD is high in the Japanese population aged 50 years or older.

Entities:  

Mesh:

Year:  2017        PMID: 28410360     DOI: 10.1097/ICO.0000000000001208

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  13 in total

1.  The association between demodex infestation and ocular surface manifestations in meibomian gland dysfunction.

Authors:  Xiao-Bo Zhang; Ying-Hui Ding; Wei He
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

2.  Meibomian gland dysfunction in geriatric population: tehran geriatric eye study.

Authors:  Hassan Hashemi; Amir Asharlous; Mohamadreza Aghamirsalim; Abbasali Yekta; Rama Pourmatin; Masoome Sajjadi; Mojgan Pakbin; Mohammadreza Asadollahi; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2021-03-24       Impact factor: 2.031

3.  A multicenter cross-sectional survey of dry eye clinical characteristics and practice patterns in Korea: the DECS-K study.

Authors:  Youngsub Eom; Joon Young Hyon; Hyung Keun Lee; Jong Suk Song; Hyo Myung Kim
Journal:  Jpn J Ophthalmol       Date:  2021-01-19       Impact factor: 2.447

4.  Association between dry eye symptoms and signs.

Authors:  Samuel Kyei; Selassie Kojo Dzasimatu; Kofi Asiedu; Patience Ansomah Ayerakwah
Journal:  J Curr Ophthalmol       Date:  2018-06-28

5.  Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes: A Multicenter Study in South Korea.

Authors:  Youngsub Eom; Kyung Sun Na; Kyong Jin Cho; Ho Sik Hwang; Sun Woong Kim; Tae Young Chung; Roo Min Jun; Jong Suk Song; Hyun Seung Kim
Journal:  Korean J Ophthalmol       Date:  2019-06

Review 6.  Meibomian Gland Dysfunction: What Have Animal Models Taught Us?

Authors:  Mingxia Sun; Isabel Y Moreno; Michelle Dang; Vivien J Coulson-Thomas
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

7.  A multi-center study evaluating the correlation between meibomian gland dysfunction and depressive symptoms.

Authors:  Zhenyu Wei; Junqi Liang; Kai Cao; Leying Wang; Christophe Baudouin; Antoine Labbé; Qingfeng Liang
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

8.  The Efficacy of Clinical Tests to Diagnose Evaporative Dry Eye Disease Related to Meibomian Gland Dysfunction.

Authors:  Jerry R Paugh; Tiffany Nguyen; Alan Sasai; Elaine Chen; Melinda Thomas De Jesus; Justin Kwan; Andrew Loc Nguyen; Marjan Farid; Sumit Garg; James V Jester
Journal:  J Ophthalmol       Date:  2022-02-10       Impact factor: 1.909

9.  Efficacy of the Systane iLux Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction After 1 Week and 1 Month: A Prospective Study.

Authors:  David Schanzlin; James P Owen; Steve Klein; Thao N Yeh; Mohinder M Merchea; Mark A Bullimore
Journal:  Eye Contact Lens       Date:  2022-04-01       Impact factor: 2.018

10.  Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period.

Authors:  Jinling Ge; Na Liu; Xiaoming Wang; Ying Du; Chaoqing Wang; Zhaorui Li; Jing Li; Lihua Wang
Journal:  BMC Ophthalmol       Date:  2020-03-18       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.